Ropivacaine Hydrochl 132112-35-7
-
Molecular Structure
Detailed Description
Product Name: Ropivacaine Hydrochloride
1. Basic Information:
Product Name Ropivacaine Hydrochloride
Synonym Ropivacaine HCL, Naropin
CAS 132112-35-7
MF C17H26N2O.ClH.H2O
MW 328.88
Assay 98%
Quality Standards USP34/Pharma Grade
Appearance White powder
Package 25kg/Drum
Place of Origin China
Brand Name SMQ
Certification ISO9001, ISO14000, KOSHER
MOQ 1kg
Packaging Details 25kg/Drum, 1kg/bag
Delivery Time 1-2 days
Payment Terms T/T, Western union, Money gram
Supply Ability 5000 T/Month
1.Overview:
Ropivacaine (rINN) is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the trade name Naropin.
2. History:
Ropivacaine was developed after bupivacaine was noted to be associated with cardiac arrest, particularly in pregnant women. Ropivacaine was found to have less cardiotoxicity than bupivacaine in animal models.
3. Clinical use
Indications:
(1) Ropivacaine is indicated for local anaesthesia including infiltration, nerve block, epidural and intrathecal anaesthesia in adults and children over 12 years. It is also indicated for peripheral nerve block and caudal epidural in children 1-12 years for surgical pain. It is also sometimes used for infiltration anaesthesia for surgical pain in children.
(2) Ropivacaine is often coadministered with fentanyl for epidural analgesia, for example in pregnant women during labour.
- Ropivacaine Hydrochl 132112-35-7